Dr. Lorenzo Bereta had spent most of his adult life trusting what could be measured. In the central hematology laboratory of Hospital San Rafaele in Milan, he built a career on procedure, repetition, and caution.
For 29 years, he examined blood from pediatric oncology patients. More than 62,000 samples had crossed his bench, each one labeled, timed, stained, counted, and filed into a world where truth arrived through instruments.
His father had given him that world. A laboratory technician in Bergamo for 40 years, he brought Lorenzo into quiet rooms of cultures, glass, and notation. Saturdays smelled of agar, disinfectant, and old paper forms.
By 17, Lorenzo already knew his future. He studied medicine at the State University of Milan, specialized in hematology and clinical microbiology, and entered San Rafaele in 1997 with a mind shaped by evidence.
Faith remained something he treated respectfully, from a distance. He had been raised Catholic, received first communion, and sometimes accompanied his mother to Mass. But the laboratory taught another reflex: distrust every claim until it can be reproduced.
On his desk at home, he kept his father’s black Pelikan fountain pen. It was not a religious relic. It was a memory of careful hands, handwritten results, and the discipline of recording what others might prefer to forget.
In October 2010, Dr. Marco Galli from Hospital San Gerardo in Monza called with a request. A biological archive connected to an acute promyelocytic leukemia case needed independent review.
The patient was Carlo Acutis, 15 years old, who had died on October 12, 2006. The Vatican had begun a beatification process, and the postulation wanted microbiological analysis before any future exhumation.
The task was not framed as a miracle investigation. It was ordinary in language: check for contamination, document degradation, verify the condition of preserved biological remains. Lorenzo accepted on October 18, 2010.
On November 22, he arrived at San Gerardo at 9:20 in the morning. The pathology corridors beneath the hospital were cold and metallic, with the disinfectant smell that every microbiologist recognizes immediately.
In the biobank, Carlo’s sample was catalogued as B2006-0847. There were four cryopreservation vials of 1 ml each: three of heparinized peripheral blood and one of marrow aspirate, stored in liquid nitrogen at -196ºC.
The thawing protocol was standard. Water bath at 37ºC for 90 seconds. Dilution 1 to 10 in RPMI 1640. Slide smear. May-Grünwald-Giemsa staining. Microscopy at 1000x under immersion oil.
Before Lorenzo began, Antonia Salzano entered the laboratory. She was Carlo’s mother, and she carried a cream-colored envelope sealed with red wax. Her voice was low, but the words were exact.
“My son asked me two days before he died that if a scientist ever examined his blood again, I should give him this envelope,” she said. “Do not open it until science runs out of answers.”
Lorenzo placed the envelope inside his white coat. He thanked her, promised respect, and returned to the cabinet. At that moment, he still believed the day would remain within professional explanation.
At 10:14, he thawed the first vial. He transferred 50 microliters onto the slide, spread the drop, dried it for 3 minutes, stained it, washed it, stained again, washed again, and dried it.
The room temperature was calibrated to 21ºC. When he touched the slide, however, the glass felt warm. The Fluke 52-2 surface thermometer read 29.4ºC. A Testo 830-T1 infrared thermometer read 29.6ºC.
Galli measured the bench, nearby instruments, and surrounding materials. Everything else registered near 21ºC. Only the slide holding Carlo Acutis’s blood radiated heat, as if some quiet source had remained inside it.
Under the microscope, the expected malignant promyelocytes were present. Carlo’s disease had been real and devastating. The sample had been taken on October 10, 2006, two days before his death, during crisis.
What stunned Lorenzo was not the diagnosis. It was preservation. After 4 years in cryopreservation, cell membranes should have shown rupture, nuclei fragmentation, granule loss, and cryodamage. Instead, the cells looked fresh.
He counted 200 cells. In the central field, 194 atypical promyelocytes were completely intact. Only six showed minimal damage. Galli repeated the count and found 198 intact cells and two with mild damage.
They questioned contamination immediately, because serious scientists question themselves first. The cabinet had been sterilized 40 minutes earlier. Gloves, pipettes, and slides were new. The procedure had been timed and documented at every step.
They thawed a second vial. This time Lorenzo measured the slide every 4 minutes for an hour. At minute 4 it read 27ºC. By minute 52, it had climbed to 29.1ºC.
The slide was not cooling toward the room. It was warming against it. Lorenzo’s right index finger began to tremble so slightly that only a person trained in precision would have noticed the danger.
Read More
At 5:10 that afternoon, Dr. Federico Richi of the Mario Negri Institute arrived. He was given the slide without the patient’s identity. For 23 minutes, he examined it in silence.
The laboratory changed around him. The centrifuge kept humming. The clock kept ticking. Galli stood with his palm flat against the bench, and a technician paused in the doorway with a clipboard lowered.
Nobody moved.
Richi finally said the sample was not 4 years old. It looked 4 hours old at most. Then Lorenzo gave him the name: Carlo Acutis. Richi walked to the wall and steadied himself with one hand.
That night Lorenzo reached home at 1:28 in the morning. The cream envelope remained unopened. Antonia had said science would run out of answers, but Lorenzo was not ready to admit that point had arrived.
Three days later, on November 25, the molecular results came by encrypted email at 8:42 a.m. Flow cytometry, quantitative PCR, PML-RARA sequencing, and viability markers all pointed in the same direction.
The annexin V and propidium iodide assay showed 87% viable cells. In blood cryopreserved for 4 years, even under excellent conditions, Lorenzo expected roughly 15 to 25%. The number looked like fresh blood.
The PML-RARA analysis confirmed the T(15;17) chromosomal translocation characteristic of M3 leukemia. The cells were not substituted. They were Carlo’s malignant cells, the same disease that had killed him.
The science I trusted had not betrayed me. It had simply reached the edge of its light.
Lorenzo called Dr. Vincenzo Esposito, a cryobiology specialist at the CNR in Naples. Esposito first asked whether the sample had been replaced. Lorenzo sent the chain of custody: intact seals, matching barcodes, uninterrupted storage.
Esposito then mentioned older anomalous tissue cases associated with canonization processes, including material attributed to Saint Catherine of Bologna and Saint Bernadette Soubirous. He did not offer theology. He offered a warning.
“What you have is not science,” Esposito told him. “It is something science can document without being able to explain.” Lorenzo wrote the words in his laboratory notebook on page 172.
Only then did he begin learning who Carlo Acutis had been. He found the Eucharistic miracle website Carlo had designed between 2002 and 2006, cataloguing 160 approved cases with dates, locations, descriptions, and scientific details.
That discovery unsettled him in a different way. Carlo had spent his adolescence documenting organic tissue that should have degraded yet had not. Now Carlo’s own blood was behaving like the cases he had archived.
On December 14, 2010, Lorenzo met Antonia Salzano in a café on Via Manzoni in Milan. She brought Carlo’s blue school notebook, the name written in black ink in the upper-right corner.
The marked page was dated September 28, 2006. Carlo had written that his blood would remain alive when his body was gone, and that the scientist would not find the answer in Milan.
The answer, Carlo wrote, would be where Thérèse wrote on July 21 in Lisieux. Lorenzo read those lines four years after Carlo had written them, and the sealed envelope suddenly felt heavier than paper.
Antonia told him Carlo had known he would go to Lisieux, but also knew it would take years. Lorenzo returned home, opened his safe, looked at the red wax, and still did not open it.
From 2010 to 2022, he continued working. He published, led research on hematopoietic cell cryopreservation, and attended conferences in Boston, Singapore, and Stockholm. The envelope remained behind his father’s Pelikan pen.
Carlo was beatified on October 10, 2020, in Assisi. Lorenzo watched the ceremony on television. In March 2021, his mother died of a sudden heart attack, and grief left him hollow.
In January 2023, at 57, Lorenzo was diagnosed with stage 2 follicular non-Hodgkin lymphoma. The irony was cruel. After decades studying oncology blood samples, he had become the patient.
His treatment began on February 6 with R-CHOP immunochemotherapy, six cycles every 21 days. February 27. March 20. April. May. June. Fatigue stayed in his bones, but the disease retreated.
After the sixth cycle, Dr. Francesca Lorenzón told him the lymphoma was in complete remission. His sister Paola suggested a quiet trip to Provence. Lorenzo answered with a word he had avoided for 13 years.
“Normandy.”
On July 18, 2023, he flew to Paris, rented a car at Charles de Gaulle, and drove 200 km west to Lisieux. His guesthouse stood 500 m from the Basilica of Saint Thérèse.
On July 21, at 9:28 in the morning, Lorenzo entered the basilica carrying the envelope. Near the north transept, before the reliquary of Saint Thérèse, his knees gave way.
He broke the red wax. Inside were a folded sheet and a small image of Saint Thérèse. The handwriting matched Carlo’s notebook. The first line addressed the doctor or doctora reading it.
“If you have arrived in Lisieux, it is because my blood spoke in the microscope,” Carlo wrote. He said he had prayed for the scientist who would one day hold his blood on a slide.
Then came the sentence Lorenzo could barely finish. Carlo wrote that the scientist’s own illness would probably arrive around 2023, when he was approximately 57 years old, but that medicine would cure him.
Carlo had dated the letter October 3, 2006, 9 days before his death. Lorenzo had been born on March 14, 1966. On July 21, 2023, he was 57 years, 4 months, and 7 days old.
The lymphoma had arrived in January 2023. Medicine had brought remission. He was in Lisieux on July 21. None of those facts connected to Carlo in any ordinary human way.
Lorenzo cried for the first time since his mother’s death. An elderly French woman with a rosary placed a hand on his shoulder and said nothing. Her silence was kinder than any explanation.
On the back of the Saint Thérèse image, Carlo had written one more line in pencil: the blood was alive because Saint Thérèse prayed while he suffered, and because the Eucharist was not a symbol.
Lorenzo left the basilica at 11:42 and sat on a stone bench outside. He read the letter three times. Then he took out his father’s black Pelikan pen and recorded the date and hour.
In the years that followed, he testified in five canonization causes. His microbiological report on Carlo’s blood was submitted officially on March 12, 2024, signed by him, Dr. Galli, and Dr. Richi.
He spoke at conferences in Boston in October 2024, Madrid in February 2025, and Rome in June 2025. Some colleagues remained skeptical. Others quietly confessed they had seen cases they never dared publish.
Esposito eventually published in 2024 on anomalous cellular integrity in tissues associated with canonization processes. The article was sparse, careful, and scientific. Three pages. Data without theology.
On September 7, 2025, Lorenzo went to Rome for the Jubilee and watched Pope Leo XIV canonize Carlo Acutis in Saint Peter’s Square. Antonia Salzano recognized him and came over with tears in her eyes.
“Carlo always knew you would be here today,” she told him. When Lorenzo asked how, she answered that her son had seen things they did not see and had prayed for him.
The original letter remains in a bank security box. A notarized copy is archived with Lorenzo’s laboratory notebook, attached to the November 22, 2010 report. The holy card stays in his white coat.
He still carries the Pelikan pen when he goes down to the laboratory. He uses it for handwritten signatures, as his father once did, because documentation is how a scientist honors the truth.
He does not ask anyone to believe what he believed. He only repeats what he measured, what two other specialists confirmed, what the chain of custody preserved, and what a dying 15-year-old wrote before it happened.
The hook was never only that Carlo Acutis touched the microbiologist who analyzed his blood 4 years later. It was that the blood, the letter, the date, and the illness all met in one place.
For 15 years, Lorenzo tried to make the event smaller than it was. In the end, the slide stayed warm, the cells remained alive, the envelope waited, and Lisieux gave him the answer Milan could not.